On-target and direct modulation of alloreactive T cells by a nanoparticle carrying MHC alloantigen, regulatory molecules and CD47 in a murine model of alloskin transplantation

References

• Angaswamy N, Tiriveedhi V, Sarma NJ, et al. (2013). Interplay between immune responses to HLA and non-HLA self-antigens in allograft rejection. Hum Immunol 74:1478–85.
   PubMed Web of Science ®Google Scholar
• Balmert SC, Little SR. (2012). Biomimetic delivery with micro- and nanoparticles. Adv Mater Weinheim 24:3757–78.
   PubMed Web of Science ®Google Scholar
• Brandhorst G, Weigand S, Eberle C, et al. (2013). CD4+ immune response as a potential biomarker of patient reported inflammatory bowel disease (IBD) activity. Clin Chim Acta 421:31–3.
   PubMed Web of Science ®Google Scholar
• Bryant J, Hlavaty KA, Zhang X, et al. (2014). Nanoparticle delivery of donor antigens for transplant tolerance in allogeneic islet transplantation. Biomaterials 35:8887–94.
   PubMed Web of Science ®Google Scholar
• Cao J, Zhu S, Zhou W, et al. (2013). PLZF mediates the PTEN/AKT/FOXO3a signaling in suppression of prostate tumorigenesis. PLoS One 8:e77922.
   PubMed Web of Science ®Google Scholar
• Champion JA, Walker A, Mitragotri S. (2008). Role of particle size in phagocytosis of polymeric microspheres. Pharm Res 25:1815–21.
   PubMed Web of Science ®Google Scholar
• Danhier F, Ansorena E, Silva JM, et al. (2012). PLGA-based nanoparticles: an overview of biomedical applications. J Control Release 161:505–22.
   PubMed Web of Science ®Google Scholar
• Fisher JD, Acharya AP, Little SR. (2015). Micro and nanoparticle drug delivery systems for preventing allotransplant rejection. Clin Immunol 160:24–35.
   PubMed Web of Science ®Google Scholar
• Garrod KR, Cahalan MD. (2008). Murine skin transplantation. J Vis Exp 16:634.
   Google Scholar
• Getts DR, Martin AJ, Mccarthy DP, et al. (2012). Microparticles bearing encephalitogenic peptides induce T-cell tolerance and ameliorate experimental autoimmune encephalomyelitis. Nat Biotechnol 30:1217–24.
   PubMed Web of Science ®Google Scholar
• Glowacki AJ, Gottardi R, Yoshizawa S, et al. (2015). Strategies to direct the enrichment, expansion, and recruitment of regulatory cells for the treatment of disease. Ann Biomed Eng 43:593–602.
   PubMed Web of Science ®Google Scholar
• Harris JM, Martin NE, Modi M. (2001). Pegylation: a novel process for modifying pharmacokinetics. Clin Pharmacokinet 40:539–51.
   PubMed Web of Science ®Google Scholar
• Hartwell BL, Antunez L, Sullivan BP, et al. (2015). Multivalent nanomaterials: learning from vaccines and progressing to antigen-specific immunotherapies. J Pharm Sci 104:346–61.
   PubMed Web of Science ®Google Scholar
• Hotaling NA, Tang L, Irvine DJ, Babensee JE. (2015). Biomaterial Strategies for Immunomodulation. Annu Rev Biomed Eng 17:317–49.
   PubMed Web of Science ®Google Scholar
• Isakov N, Segal S. (1983). Immunogenicity of the mutated H-2Kbm1 antigen(s). Test of thyroid graft rejection between B6.C-H-2bm1 and C57BL/6 mice following reciprocal immunization with normal versus malignant cells. Immunobiology 165:485–99.
   PubMed Web of Science ®Google Scholar
• Lu JM, Wang X, Marin-Muller C, et al. (2009). Current advances in research and clinical applications of PLGA-based nanotechnology. Expert Rev Mol Diagn 9:325–41.
   PubMed Web of Science ®Google Scholar
• Maldonado RA, Lamothe RA, Ferrari JD, et al. (2015). Polymeric synthetic nanoparticles for the induction of antigen-specific immunological tolerance. Proc Natl Acad Sci USA. 112:E156–65.
   PubMed Web of Science ®Google Scholar
• Masri MA. (2003). The mosaic of immunosuppressive drugs. Mol Immunol 39:1073–7.
   PubMed Web of Science ®Google Scholar
• Massarelli E, Papadimitrakopoulou V, Welsh J, et al. (2014). Immunotherapy in lung cancer. Transl Lung Cancer Res 3:53–63.
   PubMedGoogle Scholar
• Mescher MF. (1992). Surface contact requirements for activation of cytotoxic T lymphocytes. J Immunol 149:2402–5.
   PubMed Web of Science ®Google Scholar
• Meyer RA, Sunshine JC, Green JJ. (2015a). Biomimetic particles as therapeutics. Trends Biotechnol 33:514–24.
   PubMed Web of Science ®Google Scholar
• Meyer RA, Sunshine JC, Perica K, et al. (2015b). Biodegradable nanoellipsoidal artificial antigen presenting cells for antigen specific T-cell activation. Small 11:1519–25.
   PubMed Web of Science ®Google Scholar
• Oldenborg PA, Zheleznyak A, Fang YF, et al. (2000). Role of CD47 as a marker of self on red blood cells. Science 288:2051–4.
   PubMed Web of Science ®Google Scholar
• Page EK, Dar WA, Knechtle SJ. (2012). Tolerogenic therapies in transplantation. Front Immunol 3:198.
   PubMed Web of Science ®Google Scholar
• Perrault SD, Walkey C, Jennings T, et al. (2009). Mediating tumor targeting efficiency of nanoparticles through design. Nano Lett 9:1909–15.
   PubMed Web of Science ®Google Scholar
• Poon IK, Lucas CD, Rossi AG, Ravichandran KS. (2014). Apoptotic cell clearance: basic biology and therapeutic potential. Nat Rev Immunol 14:166–80.
   PubMed Web of Science ®Google Scholar
• Raich-Regue D, Glancy M, Thomson AW. (2014). Regulatory dendritic cell therapy: from rodents to clinical application. Immunol Lett 161:216–21.
   PubMed Web of Science ®Google Scholar
• Schutz C, Fleck M, Mackensen A, et al. (2008). Killer artificial antigen-presenting cells: a novel strategy to delete specific T cells. Blood 111:3546–52.
   PubMed Web of Science ®Google Scholar
• Tsai RK, Rodriguez PL, Discher DE. (2010). Self inhibition of phagocytosis: the affinity of 'marker of self' CD47 for SIRPalpha dictates potency of inhibition but only at low expression levels. Blood Cells Mol Dis 45:67–74.
   PubMed Web of Science ®Google Scholar
• Wang H, Wu X, Wang Y, et al. (2010). CD47 is required for suppression of allograft rejection by donor-specific transfusion. J Immunol 184:3401–7.
   PubMed Web of Science ®Google Scholar
• Wang W, Fang K, Li MC, et al. (2016). A biodegradable killer microparticle to selectively deplete antigen-specific T cells in vitro and in vivo. Oncotarget 7:12176–90.
   PubMedGoogle Scholar
• Wang W, Shahzad KA, Li M, et al. (2017). An antigen-presenting and apoptosis-inducing polymer microparticle prolongs alloskin graft survival by selectively and markedly depleting alloreactive CD8+ T cells. Front Immunol 8:657.
   PubMed Web of Science ®Google Scholar
• Ye F, Barrefelt A, Asem H, et al. (2014). Biodegradable polymeric vesicles containing magnetic nanoparticles, quantum dots and anticancer drugs for drug delivery and imaging. Biomaterials 35:3885–94.
   PubMed Web of Science ®Google Scholar